via University of Manchester
Scientists have discovered a new route to produce complex antibiotics exploiting gene editing to re-programme pathways to future medicines urgently required to combat antimicrobial resistance, treat neglected diseases and tackle future pandemics.
Researchers from The University of Manchester have discovered a new way of manipulating key assembly line enzymes in bacteria which could pave the way for a new generation of antibiotic treatments.
New research published today in Nature Communications, describes how CRISPR-Cas9 gene editing can be used to create new nonribosomal peptide synthetase (NRPS) enzymes that deliver clinically important antibiotics. NRPS enzymes are prolific producers of natural antibiotics such as penicillin. However, up until now, manipulating these complex enzymes to produce new and more effective antibiotics has been a major challenge.
The UK government suggest antimicrobial resistance (AMR) infections are estimated to cause 700,000 deaths each year globally and are predicted to rise to 10 million, costing the global economy $100 trillion, by 2050. AMR also threatens many of the UN’s Sustainable Development Goals (SDGs), with an extra 28 million people that could be forced into extreme poverty by 2050 unless AMR is contained.
The Manchester team says the gene editing process could be used to produce improved antibiotics and possibly lead to the development of new treatments helping in the fight against drug-resistant pathogens and illnesses in the future. Jason Micklefield, Professor of Chemical Biology at the Manchester Institute of Biotechnology (MIB), UK, explains: “The emergence of antibiotic-resistant pathogens is one of the biggest threats we face today.”
“The gene editing approach we developed is a very efficient and rapid way to engineer complex assembly line enzymes that can produce new antibiotic structures with potentially improved properties.”
The emergence of antibiotic-resistant pathogens is one of the biggest threats we face today. The gene editing approach we developed is a very efficient and rapid way to engineer complex assembly line enzymes that can produce new antibiotic structures with potentially improved properties.
Professor Jason Micklefield
Microorganisms in our environment, such as soil dwelling bacteria, have evolved nonribosomal peptide synthetase enzymes (NRPS) that assemble building blocks called amino acids into peptide products which often have very potent antibiotic activity. Many of the most therapeutically important antibiotics, used in the clinic today, are derived from these NRPS enzymes (e.g. penicillin, vancomycin and daptomycin).
Unfortunately, deadly pathogens are emerging which are resistant to all of these existing antibiotic drugs. One solution could be to create new antibiotics with improved properties that can evade the resistance mechanisms of the pathogens. However, the nonribosomal peptide antibiotics are very complex structures which are difficult and expensive to produce by normal chemical methods. To address this, the Manchester team use gene editing to engineer the NRPS enzymes, swapping domains that recognise different amino acid building blocks, leading to new assembly lines that can deliver new peptide products.
Micklefield added: “We are now able to use gene editing to introduce targeted changes to complex NRPS enzymes, enabling alternative amino acids precursors to be incorporated into the peptide structures. We are optimistic that our new approach could lead to new ways of making improved antibiotics which are urgently needed to combat emerging drug-resistant pathogens.”
Original Article: Manchester scientists produce new antibiotics by gene editing
More from: University of Manchester
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
New antibiotics development
- Sophisticated mechanism that bacteria use to resist antibiotics
Researchers have discovered a significant and previously unknown mechanism that many bacteria use to resist antibiotics.
- Bipartisan bill on antibiotics faces crucial stretch
A health care bill is facing criticism from some experts who say it could lead to huge spending on new antibiotic drug development that may not improve patient outcomes in the long run. The bipartisan ...
- New breakthrough shows antimicrobial resistance is more evolved than previously recognized
Researchers have discovered a significant and previously unknown mechanism that many bacteria use to resist antibiotics.
- Antibiotic exposure in early childhood linked to later development of asthma and allergies
Early exposure to antibiotics kills healthy bacteria in the digestive tract and can cause asthma and allergies, a new study demonstrates.
- Typhoid mutated to beat antibiotics. Science is learning how to beat those strains
The ancient disease is still a killer. And even though there are new drugs, there's a growing rate of antibiotic-resistance cases. Here's a look at the latest strategies to tame typhoid.
Go deeper with Google Headlines on:
New antibiotics development
Go deeper with Bing News on:
Antibiotic treatments
- Sophisticated mechanism that bacteria use to resist antibiotics
Researchers have discovered a significant and previously unknown mechanism that many bacteria use to resist antibiotics.
- American Academy of Family Physicians Awarded $31 Million for Comparative Asthma Treatment Study
The Patient-Centered Outcomes Research Institute (PCORI) has approved an award for the American Academy of Family Physicians (AAFP) of $31 million to fund a large comparative study of asthma ...
- Early recognition, prompt treatment important in managing pediatric enterocolitis
Early recognition and prompt administration of antibiotics are important factors in managing neutropenic enterocolitis, a common and potentially life-threatening condition that can befall pediatric ...
- New trial offers double the traditional course of antibiotics for patients with life threatening infections
Hospital patients who develop infections where 10% of sufferers die will be offered double the traditional course of antibiotics in a new trial.
- Taking This Common Antibiotic After Sex Might Help Prevent STDs
A new study claims a common antibiotic can help prevent STDs, which have been on the rise following the pandemic.